Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: A review

O. M. Avrech, A. Golan, Z. Weinraub, I. Bukovsky, E. Caspi

Research output: Contribution to journalArticlepeer-review

Abstract

The availability of a medical mode of termination of early pregnancy by the administration of RU486, an antiprogesterone alone, or in combination with one of the PG analogues significantly reduces the maternal morbidity and mortality associated with the classical surgical abortion. RU486 given alone in early pregnancy induces complete abortion in 60% to 85% of cases, and when combined with prostaglandin analogues, gemeprost or sulprostone, reaches a success rate of 95% to 99%. RU486 may also be of potential value in the medical treatment of ectopic pregnancy. Its use as a postcoital contraception is suggested, but further research is required to determine whether RU486 can be used on a once-a-month basis for contraception.

Original languageEnglish
Pages (from-to)385-393
Number of pages9
JournalFertility and Sterility
Volume56
Issue number3
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Dive into the research topics of 'Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: A review'. Together they form a unique fingerprint.

Cite this